We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-1.57%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.01B
AUM Growth
+$206M
Cap. Flow
+$143M
Cap. Flow %
3.56%
Top 10 Hldgs %
9.67%
Holding
2,888
New
685
Increased
559
Reduced
490
Closed
695

Sector Composition

Rank Sector Weight
1 Financials 14.79%
2 Technology 9.23%
3 Healthcare 8.54%
4 Consumer Discretionary 6.86%
5 Industrials 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANEB
2076
DELISTED
Anebulo Pharmaceuticals
ANEB
$48K ﹤0.01%
17,319
-14
-0.1% -$50
GGB icon
2077
Gerdau
GGB
$9.7B
$48K ﹤0.01%
+13,356
New +$48.5K
ABEV icon
2078
Ambev
ABEV
$46.4B
$47K ﹤0.01%
+16,500
New +$46.8K
AIMDW icon
2079
Ainos Warrants
AIMDW
$80.7K
$47K ﹤0.01%
+25,000
New +$16.1K
GBRGR
2080
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$47K ﹤0.01%
310,317
WTMAR
2081
DELISTED
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of common stock
WTMAR
$47K ﹤0.01%
621,600
TME icon
2082
Tencent Music
TME
$15.6B
$46K ﹤0.01%
+11,300
New +$51.4K
LMDX
2083
DELISTED
LumiraDx Limited Common Shares
LMDX
$45K ﹤0.01%
+43,735
New +$72.6K
GRAB icon
2084
Grab
GRAB
$14.9B
$44K ﹤0.01%
+16,800
New +$50.9K
CPTNW
2085
DELISTED
Cepton, Inc. Warrant
CPTNW
$44K ﹤0.01%
22,591
CLVS
2086
DELISTED
Clovis Oncology, Inc.
CLVS
$43K ﹤0.01%
36,350
-18,531
-34% -$28.9K
FNCH
2087
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$40K ﹤0.01%
796
-578
-42% -$40.2K
CELZ icon
2088
Creative Medical Technology
CELZ
$9.21M
$39K ﹤0.01%
8,889
FLFVR
2089
DELISTED
Feutune Light Acquisition Corporation Right
FLFVR
$39K ﹤0.01%
+643,125
New +$47.5K
CLRCR
2090
DELISTED
ClimateRock Right
CLRCR
$38K ﹤0.01%
300,000
MOBBW
2091
Mobilicom Ltd Warrants
MOBBW
$2.83B
$37K ﹤0.01%
+20,300
New +$7.82K
ATAKR
2092
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$37K ﹤0.01%
585,000
BIAFW icon
2093
bioAffinity Technologies
BIAFW
$36K ﹤0.01%
+12,500
New +$13K
CNTB
2094
Connect Biopharma Holdings
CNTB
$139M
$35K ﹤0.01%
26,867
-50,984
-65% -$61.3K
ASCBR
2095
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$34K ﹤0.01%
450,000
LGHLW
2096
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$33K ﹤0.01%
32,895
RPID icon
2097
Rapid Micro Biosystems
RPID
$86.2M
$33K ﹤0.01%
10,073
-8,671
-46% -$33.6K
RFACR
2098
DELISTED
RF Acquisition Corp. Rights
RFACR
$32K ﹤0.01%
400,000
AIBBR
2099
DELISTED
AIB Acquisition Corp Right
AIBBR
$31K ﹤0.01%
350,000
STIXW
2100
DELISTED
Semantix, Inc. Warrant
STIXW
$31K ﹤0.01%
+11,870
New +$1.9K

Similar funds

Boothbay Fund Management's Q3 2022 Portfolio in Review

As of Q3 2022, Boothbay Fund Management held 2,888 positions worth $4.01B, up 5.4% from $3.8B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Boothbay Fund Management deployed $143M of net new capital in Q3 2022, opening 685 new positions and adding to 559 existing holdings. Its largest new stake was Cornerstone Strategic Value Fund: 3,810,000 shares worth $32.1M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Expand Energy Corp, an estimated $16.6M trimmed.

  • Boothbay Fund Management's largest Q3 2022 buy was Cornerstone Strategic Value Fund: 3,810,000 shares worth $32.1M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q3 2022, an estimated $18.2M increase.
  • Boothbay Fund Management's biggest Q3 2022 reduction was Expand Energy Corp, cutting an estimated $16.6M.
  • Boothbay Fund Management fully exited International Media Acquisition Corp. Class A Common Stock in Q3 2022, selling an estimated $19.9M.
  • Boothbay Fund Management's ten largest holdings make up 9.7% of its $4.01B portfolio in Q3 2022.
  • Boothbay Fund Management opened 685 new positions and closed 695 in Q3 2022.
  • Boothbay Fund Management's portfolio value rose 5.4% quarter-over-quarter to $4.01B.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.